Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology

Volumn 40, Issue 1, 2016, Pages 51-56

  Wang, Yi Lin ^a   Chen, Chi mei ^b   Wang, Xiao Ming ^c   Wang, Lu ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c Yijishan Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 339 5P; UNCLASSIFIED DRUG; MIRN339 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR INVASION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 84959572834     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.05.022     Document Type: Article

References (24)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64(1):9-29. 10.3322/caac.21208.
2. Schwartz M., Roayaie S., Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nature clinical practice. Oncology 2007, 4(7):424-432. 10.1038/ncponc0844.
3. Poon R.T., Fan S.T. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 2004, 10(2 Suppl. 1):S39-S45. 10.1002/lt.20040.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
5. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122(1):6-7. 10.1016/j.cell.2005.06.036.
6. Gregory R.I., Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005, 65(9):3509-3512. 10.1158/0008-5472.CAN-05-0298.
7. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838. 10.1038/nature03702.
8. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103(7):2257-2261. 10.1073/pnas.0510565103.
9. Wu Z.S., Wang C.Q., Xiang R., et al. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 2012, 12:51. 10.1186/1471-2407-12-51.
10. Wu Z.S., Wu Q., Wang C.Q., et al. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 2010, 10:542. 10.1186/1471-2407-10-542.
11. Zhou C., Liu G., Wang L., et al. MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1. Plos One 2013, 8(5):e63142. 10.1371/journal.pone.0063142.
12. Zuo Q., Huang H., Shi M., et al. Multivariate analysis of several molecular markers and clinicopathological features in postoperative prognosis of hepatocellular carcinoma. Anat Rec (Hoboken) 2012, 295(3):423-431. 10.1002/ar.21531.
13. Kwak M.S., Lee J.H., Yoon J.H., et al. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci 2012, 57(3):813-819. 10.1007/s10620-011-1995-1.
14. Su C.W., Lei H.J., Chau G.Y., et al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg 2012, 147(2):137-144. 10.1001/archsurg.2011.288.
15. Wong K.F., Xu Z., Chen J., Lee N.P., Luk J.M. Circulating markers for prognosis of hepatocellular carcinoma. Expert Opin Med Diagn 2013, 7(4):319-329. 10.1517/17530059.2013.795146.
16. Chen P., Zhao X., Ma L. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 2013, 383(1-2):49-58. 10.1007/s11010-013-1753-0.
17. Giordano S., Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?. Hepatology 2013, 57(2):840-847. 10.1002/hep.26095.
18. Gu H., Guo X., Zou L., Zhu H., Zhang J. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol Cell Biochem 2013, 375(1-2):23-30. 10.1007/s11010-012-1521-6.
19. Huang X.Y., Yao J.G., Huang H.D., et al. MicroRNA-429 modulates hepatocellular carcinoma prognosis and tumorigenesis. Gastroenterol Res Pract 2013, 2013:804128. 10.1155/2013/804128.
20. Kitagawa N., Ojima H., Shirakihara T., et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013, 104(5):543-551. 10.1111/cas.12126.
21. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12(12):861-874. 10.1038/nrg3074.
22. Kim M., Kasinski A.L., Slack F.J. MicroRNA therapeutics in preclinical cancer models. The Lancet. Oncology 2011, 12(4):319-321. 10.1016/S1470-2045(11)70067-5.
23. Patnaik S.K., Kannisto E., Knudsen S., Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 2010, 70(1):36-45. 10.1158/0008-5472.CAN-09-3153.
24. Liu A., Tetzlaff M.T., Vanbelle P., et al. MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol 2009, 2(6):519-527.